← Leaderboards
Valery I Shestopalov
Washington University
$7,779,594
Attributed
$9,373,203
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2005–22$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$9,373,203 · 8
By mechanism
R01$8,063,095 · 3
R21$1,036,753 · 3
P30$273,355 · 2
Top collaborators
- Russell N Van Gelder5 shared
Most similar at Washington University
Same institution · by research overlap
- David Beebe$14,789,729
- Usha P Andley$7,676,267
- Russell N Van Gelder$16,133,253
- Kristine M. Wylie$7,245,177
- Ying-Bo Shui$22,841
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularBlindnessPathway InteractionsBaseResponseTissuesAffectNeurotoxicNeuronsRetinaRetinal Ganglion CellsMediatingDesignNeuron LossChronicOcular HypertensionInjuryProteinsGlaucomaPreventPhysiologicalPathologicPhysiologic Intraocular PressureCataract
Grant awards (29)
Role of gasderminD in ganglion cell dysfunction and injury$186,118
R21 · FY2022 · EY · contact PI
Role of gasderminD in ganglion cell dysfunction and injury$221,345
R21 · FY2021 · EY · contact PI
Biological Imaging Core$133,576
P30 · FY2021 · EY · contact PI
The Role of Pannexin 1 Pathway in Ocular Hypertension Injury of Retinal Ganglion Cells$453,968
R01 · FY2020 · EY · contact PI
The Role of Pannexin 1 Pathway in Ocular Hypertension Injury of Retinal Ganglion Cells$124,385
R01 · FY2020 · EY · contact PI
The Role of Pannexin 1 Pathway in Ocular Hypertension Injury of Retinal Ganglion Cells$453,967
R01 · FY2019 · EY · contact PI
Biological Imaging$139,779
P30 · FY2019 · EY · contact PI
The Role of Pannexin 1 Pathway in Ocular Hypertension Injury of Retinal Ganglion Cells$453,968
R01 · FY2018 · EY · contact PI
The Role of Pannexin 1 Pathway in Ocular Hypertension Injury of Retinal Ganglion Cells$515,795
R01 · FY2017 · EY · contact PI
Diversity and Dynamic Stability of the Ocular Surface Microbiome$630,621
R01 · FY2016 · EY
Diversity and Dynamic Stability of the Ocular Surface Microbiome$621,453
R01 · FY2015 · EY
Diversity and Dynamic Stability of the Ocular Surface Microbiome$647,740
R01 · FY2014 · EY
The Role of Pannexin1 in Ischemic Injury of Retinal Ganglion Cells$374,850
R01 · FY2014 · EY · contact PI
Diversity and Dynamic Stability of the Ocular Surface Microbiome$630,276
R01 · FY2013 · EY
The Role of Pannexin1 in Ischemic Injury of Retinal Ganglion Cells$363,375
R01 · FY2013 · EY · contact PI
Diversity and Dynamic Stability of the Ocular Surface Microbiome$657,129
R01 · FY2012 · EY
The Role of Pannexin1 in Ischemic Injury of Retinal Ganglion Cells$372,710
R01 · FY2012 · EY · contact PI
Metagenomic Analysis of Ocular Surface Microbiome$228,000
R21 · FY2010 · EY · contact PI
Organization of the lens core syncytium$216,759
R01 · FY2008 · EY · contact PI
The role of NFkB in glia-neuron crosstalk in glaucoma$187,425
R21 · FY2008 · EY · contact PI
Organization of the lens core syncytium$220,667
R01 · FY2007 · EY · contact PI
The role of NFkB in glia-neuron crosstalk in glaucoma$213,865
R21 · FY2007 · EY · contact PI
Organization of the lens core syncytium$221,910
R01 · FY2006 · EY · contact PI
Organization of the lens core syncytium$227,250
R01 · FY2005 · EY
Organization of the lens core syncytium$291,784
R01 · FY2004 · EY
Organization of the lens core syncytium$227,250
R01 · FY2003 · EY
Organization of the lens core syncytium$75,218
R01 · FY2003 · EY
Organization of the lens core syncytium$193,221
R01 · FY2002 · EY
Organization of the lens core syncytium$88,799
R01 · FY2002 · EY